WDC
RDHL

Woodward Diversified Capital’s Redhill Biopharma RDHL Stock Holding History

Woodward Diversified Capital’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-17
Closed -$78K – 210
2021
Q3 		$78K Sell
17
-22
-56% -$149K 0.05% 184
2021
Q2 		$267K Buy
39
+22
+129% +$152K 0.15% 159
2021
Q1 		$128K Sell
17
-6
-26% -$50.3K 0.08% 196
2020
Q4 		$186K Buy
+23
New +$207K 0.12% 153

Other funds holding RDHL

DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $837M AUM 25.51% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Woodward Diversified Capital's RDHL Position: Q4 2021 in Review

Woodward Diversified Capital sold out of Redhill Biopharma (RDHL) in Q4 2021, closing a stake of 17 shares — an estimated $78K sold.

Woodward Diversified Capital first reported a position in RDHL in Q4 2020 and held it in 4 quarters. The position peaked at $267K in Q2 2021. 51 funds tracked by Wall St. Rank hold RDHL as of Q4 2021.

  • Woodward Diversified Capital reported no remaining Redhill Biopharma position as of Q4 2021 after selling out during the quarter.
  • Woodward Diversified Capital sold 17 Redhill Biopharma shares in Q4 2021, an estimated $78K.
  • Woodward Diversified Capital first reported a position in Redhill Biopharma in Q4 2020 and held it in 4 quarters.
  • Woodward Diversified Capital's Redhill Biopharma position peaked at $267K in Q2 2021.
  • 51 funds tracked by Wall St. Rank held Redhill Biopharma as of Q4 2021.

Based on Woodward Diversified Capital's 13F filing for Q4 2021, filed 28 Jan 2022.